Source comparison
Best BPC-157 Dosage IBS Support 2026: Protocol Comparison
This table compares the three most common BPC-157 protocols used in IBS research and their documented outcomes in gastrointestinal studies. Conservative Start 500mcg total (250mcg × 2) Twice daily (12-hour intervals) Subcutaneous abdominal 4–6 weeks Best for m
This comparison does not assign a generated winner or score.
- This table compares the three most common BPC-157 protocols used in IBS research and their documented outcomes in gastrointestinal studies.
- Conservative Start
- 500mcg total (250mcg × 2)
- Twice daily (12-hour intervals)
- Subcutaneous abdominal
- 4–6 weeks
- Best for mild-to-moderate symptoms and first-time peptide users; allows tolerance assessment before escalation
- Standard Therapeutic
- 700mcg total (350mcg × 2)
- 6–8 weeks
- Most commonly cited range in gastrointestinal research; balances efficacy with peptide consumption efficiency
- Intensive Repair
- 1000mcg total (500mcg × 2)
- 8–12 weeks
- Reserved for severe mucosal damage or refractory cases; exceeding this dose shows diminishing returns in tissue repair velocity